Biologics Will Pump Up the Vasculitis Market.

Chris, Fellner

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2016

Data sources: Europe PubMed Central

Biologics Will Pump Up the Vasculitis Market.

descriptionPublicationkeyboard_double_arrow_right Article 12 Apr 2016 English Journal:P & T : a peer-reviewed journal for formulary management, volume 41 (issn: 1052-1372,

Copyright policy )

Authors: Chris, Fellner;

pmid: 27069346

pmc: PMC4811257

Biologics Will Pump Up the Vasculitis Market.

- Summary
- Metrics

Abstract

Vasculitis, a group of heterogeneous disorders characterized by inflammation and necrosis of the blood vessels, has but one treatment approved by the Food and Drug Administration. However, six novel biologic candidates are in late-stage development.

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average